ICU Medical, Inc. (ICUI) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | 38.91M | 60.6M | 56.71M | 11.21M | 51.33M | 40.19M | 36.1M | 81.95M | 45.79M | 91.27M | 35.16M | -1.47M |
| Operating CF Margin % | 7.34% | 11.22% | 10.56% | 2.04% | 8.49% | 6.38% | 6.13% | 13.74% | 8.08% | 15.53% | 6.35% | -0.27% |
| Operating CF Growth % | -24.19% | 50.77% | 57.1% | -86.32% | 12.09% | -55.96% | 2.66% | 5659.9% | 11.02% | 5434.25% | 1422.78% | 97.6% |
| Net Income | 30.13M | -15.73M | -3.4M | 35.34M | -15.48M | -23.83M | -32.98M | -21.41M | -39.47M | -17.15M | 7.24M | -9.93M |
| Depreciation & Amortization | 50.03M | 54.34M | 52.43M | 49.66M | 49.45M | 52.99M | 55.67M | 55.32M | 55.53M | 57.16M | 58.37M | 59.2M |
| Stock-Based Compensation | 14.01M | 0 | 15.24M | 14.46M | 12.18M | 12.52M | 11.77M | 11M | 11.6M | 10.69M | 10.95M | 9.77M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -19.53M | -12.6M | 0 |
| Other Non-Cash Items | 8.68M | 28.84M | 18.21M | -39.16M | 17.09M | 16.18M | 15.12M | 12.56M | 14.04M | 46.05M | 8.92M | -14.44M |
| Working Capital Changes | -63.94M | -6.84M | -25.78M | -49.08M | -11.91M | -17.67M | -13.49M | 24.49M | 4.1M | 14.06M | -37.71M | -46.08M |
| Change in Receivables | -24.14M | 4.93M | -12.75M | -5.75M | 22.44M | -35.33M | -18.23M | -7.25M | 13.97M | 5.55M | -3.71M | -35.23M |
| Change in Inventory | 6.09M | 9.96M | -7M | -20.99M | -8.22M | 7.41M | -11.68M | 6.93M | 14.16M | 60.58M | 9.38M | -26.67M |
| Change in Payables | 20.15M | -16.33M | 0 | -17.72M | 32.1M | -8.55M | 11.65M | 4.12M | 5.31M | -3.25M | -18.18M | 0 |
| Cash from Investing | -11.21M | -18.39M | -30.03M | 187.46M | -16.81M | -26.55M | -22.86M | -21.69M | -17.86M | -30.65M | -24.51M | -17.61M |
| Capital Expenditures | -11.3M | -26.41M | -29.08M | -19.7M | -14.62M | -24.08M | -14.55M | -21.88M | -15.91M | -31.97M | -24.56M | -18.28M |
| CapEx % of Revenue | 2.13% | 4.89% | 5.42% | 3.59% | 2.42% | 3.82% | 2.47% | 3.67% | 2.81% | 5.44% | 4.44% | 3.33% |
| Acquisitions | 0 | 219.2M | 0 | 0 | 0 | 0 | -692K | 185K | 0 | 20K | 50K | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 93K | -211.19M | -948K | 207.16M | -2.19M | -2.46M | -7.62M | 0 | -2.45M | -1.43M | 0 | 678K |
| Cash from Financing | -44.12M | -34.48M | -25.69M | -195.01M | -56.34M | -8.19M | -10.38M | -10.38M | -26.84M | -7.85M | -6.4M | -5.9M |
| Debt Issued (Net) | -5.35M | -34.57M | -25.66M | -200.56M | -48.08M | -13.12M | -10.41M | -13.02M | -12.99M | -7.72M | -7.68M | -7.67M |
| Equity Issued (Net) | 0 | -8.63M | -31K | 5.84M | 133K | -6.94M | 2.81M | 2.92M | 0 | -9.35M | 1.79M | -293K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -11.48M | 0 | 0 |
| Share Repurchases | 0 | -8.77M | -31K | 0 | 0 | -11.99M | 0 | 0 | 0 | -9.35M | 0 | -293K |
| Other Financing | -38.78M | 8.72M | 0 | -297K | -8.39M | 11.87M | -2.78M | -285K | -13.85M | 20.7M | -503K | 2.06M |
| Net Change in Cash | -19.63M | 8.23M | -293K | 10.32M | -18.86M | -3.95M | 9.86M | 51.23M | -2.8M | 57.03M | 1.3M | -25.06M |
| Free Cash Flow | 27.61M | 35.95M | 27.63M | -10.79M | 36.71M | 13.6M | 21.55M | 62.49M | 26.92M | 59.3M | 10.6M | -19.76M |
| FCF Margin % | 5.21% | 6.65% | 5.15% | -1.97% | 6.07% | 2.16% | 3.66% | 10.48% | 4.75% | 10.09% | 1.92% | -3.6% |
| FCF Growth % | -24.79% | 164.46% | 28.21% | -117.27% | 36.34% | -77.07% | 103.25% | 416.26% | -0.44% | 354.42% | 151.75% | 76.98% |
| FCF per Share | 1.10 | 1.46 | 1.12 | -0.44 | 1.50 | 0.56 | 0.88 | 2.56 | 1.11 | 2.46 | 0.44 | -0.82 |
| FCF Conversion (FCF/Net Income) | 1.29x | -3.85x | -16.70x | 0.32x | -3.32x | -1.69x | -1.09x | -3.83x | -1.16x | -5.32x | 4.86x | 0.15x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |